Semaglutide injections start at $199/mo, but the cost increases as your dose goes up, reaching $299/mo at higher doses
Baseline cardiovascular assessment should include detailed history of prior cardiovascular events, current symptoms, blood pressure measurement, lipid profile, renal function assessment, and calculation of 10-year atherosclerotic cardiovascular disease (ASCVD) risk using validated tools such as the Pooled Cohort Equations
A randomized controlled trial showed that patients undergoing liraglutide therapy exhibited reduced systemic inflammation and skin lesion severity, which supports its adjunctive use in Pso management [59]
Dapagliflozin monotherapy in type 2 diabetic patients with inadequate glycemic control by diet and exercise: A randomized, double-blind, placebo-controlled, phase 3 trial
These patches may improve patient adherence by reducing pain associated with injections and eliminating the need for cold chain storage
Cardiovascular Protection: Major clinical trials like the LEADER trial for liraglutide have shown that GLP-1 RAs can significantly reduce the risk of major adverse cardiovascular events, such as heart attacks and strokes, in patients with type 2 diabetes
